d

de Duve Institute/ Nouscom

36 employees

Nouscom are a biotech company working to develop a series of new, potent immunotherapeutics capable of selectively killing tumor cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Genetics

Date founded

2015

Funding rounds raised

Total raised

$49M

from 6 investors over 6 rounds

d

de Duve Institute/ Nouscom raised $49M on November 6, 2017

Investors: 5AM Ventures, Versant Ventures, Abingworth and LSP (Life Sciences Partners)

d

de Duve Institute/ Nouscom raised $14M on May 17, 2016

Investors: EQT Life Sciences and Versant Ventures

FAQ